Science & Research

A recent study by the Kansas State University College of Veterinary Medicine found that feeding cattle CBDA-rich hemp decreased the animals’ stress hormone cortisol and inflammation biomarkers.

The U.S. House approved a bipartisan cannabis research bill this week that would expand research possibilities and let researchers study cannabis products acquired through state-legal markets.

Researchers at Rensselaer Polytechnic Institute have developed hemp-based rebar for concrete construction projects that should both last longer and carry a smaller carbon footprint than steel rebar.

A recent poll found that less than half of U.S. parents know much about the use of CBD products with regard to children and most have never tried CBD themselves.

A recent survey found that cannabis consumers have more sex than non-consumers. Additionally, 65% of sexually active cannabis consumers agree that the plant enhances their sex life and helps them get in the mood for sex.

A new study published in the American Journal of Preventive Medicine found that two in five drivers who reported using alcohol and cannabis in the past year drove under the influence.

A new study has found that at least half of participants who smoke cannabis had a significantly diminished ability to drive compared to subjects who smoked a placebo cigarette.

Flora Growth Corp. submitted an application to Colombian regulators for researching whether a cannabinoid-based product can help prevent COVID-19 infections.

The University of Mississippi launched the National Center for Cannabis Research and Education to conduct scientific research and aid in policymaking and legalization-related outreach.

According to a recent survey, respondents between the ages of 18 to 30 who use cannabis and alcohol have better sexual functions and orgasms than those that don’t consume either.

A new survey found 88.8% of patients with a skin condition would try a medical cannabis-based treatment.

Researchers at the University of Mississippi have been awarded $1.37 million to study if cannabis can help manage HIV-related pain in patients.

The biotech pharma firm ANANDA Scientific Inc. announced it has received FDA approval to study a CBD-based drug as a treatment for opioid-use disorder.

Groff North America Hemplex and BRC, two cannabis cultivation firms, have harvested federally sanctioned cannabis for research purposes, ending a 50-year monopoly by the University of Mississippi.

A recent study found significant improvement in autism symptoms following treatment with THC-rich cannabis oil.

A recent study found that cannabis decriminalization policies have helped to reduce the racial disparity in cannabis possession arrests.

A set of GOP companion bills in the House and Senate seeking to curb illegal fentanyl sales would also streamline the research of cannabis, psychedelics, and other Schedule I substances.

Researchers at the University of Sydney in Australia have found that blood and oral fluid THC concentrations are weak indicators of cannabis-induced impairment.

A new study found that psilocybin may be able to reverse alcohol brain damage, reduce alcohol-addictive behavior, and reduce relapse rates.

NORML released an updated and revised version of “Clinical Applications for Cannabis & Cannabinoids: A Review of the Recent Scientific Literature, 2000-2021.” Proceeds from the book will be used to fund NORML’s advocacy efforts.

A recent survey found 65% of patients were able to reduce or eliminate taking at least one prescription medication after obtaining their medical cannabis registration.

Baltimore’s Johns Hopkins Medicine announced that the National Institutes of Health will provide nearly $4 million to help researchers study how psilocybin can affect tobacco addiction.

Bank of America suddenly canceled the account of cannabis research firm Scottsdale Research Institute despite being fully compliant with federal laws and operating with public DEA approval.

The DEA has proposed massively increasing the production of research-grade cannabis and psychedelics like LSD, psilocybin, and MDMA next year.